89 related articles for article (PubMed ID: 14613510)
21. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations.
Boyle MJ; Jagannathan P; Bowen K; McIntyre TI; Vance HM; Farrington LA; Greenhouse B; Nankya F; Rek J; Katureebe A; Arinaitwe E; Dorsey G; Kamya MR; Feeney ME
J Infect Dis; 2015 Aug; 212(3):416-25. PubMed ID: 25646355
[TBL] [Abstract][Full Text] [Related]
22. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
[TBL] [Abstract][Full Text] [Related]
23. Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro.
Troye-Blomberg M; Andersson G; Stoczkowska M; Shabo R; Romero P; Patarroyo ME; Wigzell H; Perlmann P
J Immunol; 1985 Nov; 135(5):3498-504. PubMed ID: 3930605
[TBL] [Abstract][Full Text] [Related]
24. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
[TBL] [Abstract][Full Text] [Related]
25. Frequency of cytokine-producing CD4-CD8- peripheral blood mononuclear cells in patients with Plasmodium falciparum malaria.
Winkler S; Willheim M; Baier K; Graninger W; Kremsner PG
Eur Cytokine Netw; 1999 Jun; 10(2):155-60. PubMed ID: 10400821
[TBL] [Abstract][Full Text] [Related]
26. Identification of HLA-A24 restricted pre-erythrocytic stage specific T-cell epitopes using Plasmodium falciparum synthetic peptides: a preliminary study.
Tippawangkosol P; Duangchanda T; Ubalee R; Ruengweerayut R; Hirayama K; Na-Bangchang K
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):10-7. PubMed ID: 19323028
[TBL] [Abstract][Full Text] [Related]
27. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
Høgh B
Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.
Takala SL; Coulibaly D; Thera MA; Dicko A; Smith DL; Guindo AB; Kone AK; Traore K; Ouattara A; Djimde AA; Sehdev PS; Lyke KE; Diallo DA; Doumbo OK; Plowe CV
PLoS Med; 2007 Mar; 4(3):e93. PubMed ID: 17355170
[TBL] [Abstract][Full Text] [Related]
29. Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria.
Winkler S; Willheim M; Baier K; Schmid D; Aichelburg A; Graninger W; Kremsner PG
J Infect Dis; 1999 Jan; 179(1):209-16. PubMed ID: 9841841
[TBL] [Abstract][Full Text] [Related]
30. HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.
May J; Lell B; Luty AJ; Meyer CG; Kremsner PG
J Infect Dis; 2001 Jan; 183(1):168-72. PubMed ID: 11076705
[TBL] [Abstract][Full Text] [Related]
31. Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.
Dent AE; Bergmann-Leitner ES; Wilson DW; Tisch DJ; Kimmel R; Vulule J; Sumba PO; Beeson JG; Angov E; Moormann AM; Kazura JW
PLoS One; 2008; 3(10):e3557. PubMed ID: 18958285
[TBL] [Abstract][Full Text] [Related]
32. Age-dependency of Plasmodium falciparum-specific and non-specific T cell cytokine responses in individuals from a malaria-endemic area.
Ramharter M; Winkler H; Kremsner PG; Adegnika AA; Willheim M; Winkler S
Eur Cytokine Netw; 2005 Jun; 16(2):135-43. PubMed ID: 15941685
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
[TBL] [Abstract][Full Text] [Related]
35. Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.
D'Ombrain MC; Robinson LJ; Stanisic DI; Taraika J; Bernard N; Michon P; Mueller I; Schofield L
Clin Infect Dis; 2008 Dec; 47(11):1380-7. PubMed ID: 18947328
[TBL] [Abstract][Full Text] [Related]
36. Age-dependent antibody response to Plasmodium falciparum merozoite surface protein 2 (MSP-2).
Khosravi A; Hommel M; Sayemiri K
Parasite Immunol; 2011 Mar; 33(3):145-57. PubMed ID: 21306398
[TBL] [Abstract][Full Text] [Related]
37. Interferon-
Sylvester B; Gasarasi DB; Aboud S; Tarimo D; Masawe S; Mpembeni R; Swedberg G
J Trop Med; 2018; 2018():6847498. PubMed ID: 30154871
[TBL] [Abstract][Full Text] [Related]
38. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.
Kempaiah P; Anyona SB; Raballah E; Davenport GC; Were T; Hittner JB; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Aug; 131(8):1375-91. PubMed ID: 22570109
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya.
Kisia LE; Cheng Q; Raballah E; Munde EO; McMahon BH; Hengartner NW; Ong'echa JM; Chelimo K; Lambert CG; Ouma C; Kempaiah P; Perkins DJ; Schneider KA; Anyona SB
Trop Med Health; 2022 Jun; 50(1):41. PubMed ID: 35752805
[TBL] [Abstract][Full Text] [Related]
40. T follicular helper cell profiles differ by malaria antigen and for children compared to adults.
Forconi CS; Nixon C; Wu HW; Odwar B; Pond-Tor S; Ong'echa JM; Kurtis J; Moormann AM
bioRxiv; 2024 Apr; ():. PubMed ID: 38659768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
